| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10428194.2017.1295146 |
| P698 | PubMed publication ID | 28278708 |
| P2093 | author name string | Masaharu Nohgawa | |
| Satoko Oka | |||
| Kazuo Ono | |||
| P2860 | cites work | p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q). | Q33695954 |
| New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge | Q36920348 | ||
| Genetic complexity of myeloproliferative neoplasms. | Q37255024 | ||
| Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet | Q37263146 | ||
| The 5q-anomaly | Q39822203 | ||
| Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation | Q42905791 | ||
| Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31 | Q44637369 | ||
| A novel t(2;17) in transformation of essential thrombocythemia to acute myelocytic leukemia. | Q44707550 | ||
| JAK2 V617F mutation is associated with 5q- syndrome in Chinese. | Q54735977 | ||
| The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow | Q58865932 | ||
| P433 | issue | 10 | |
| P921 | main subject | acute myeloid leukemia | Q264118 |
| myelodysplastic syndrome | Q954625 | ||
| P304 | page(s) | 2511-2513 | |
| P577 | publication date | 2017-02-28 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide | |
| P478 | volume | 58 |
Search more.